Description
COST PER TEST
First action · last action
2011-12-01 · 2012-03-01
Transactions
2
First transaction's obligation
$334,758
Base + all options value (sum of deltas)
$1,115,860
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
3
SDVOSB flag on record
No
Parent IDV
V797P5478X
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-12-01+$334,758= $334,758
- Mod 12012-03-01+$781,102= $1,115,860
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-12-01 | +$334,758 | $334,758 | COST PER TEST |
| Mod 1· EXERCISE AN OPTION | 2012-03-01 | +$781,102 | $1,115,860 | COST PER TEST |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NH3LDK8CFAK7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N1004 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $187,594 | FY2026 |
| 36C24426N1005 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $395,322 | FY2026 |
| 36C24426N1001 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $431,969 | FY2026 |
| 36C24426N1003 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $267,954 | FY2026 |
| 36C24426N1002 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $607,544 | FY2026 |
| 36C24426N1006 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $783,641 | FY2026 |
Other recipients under Q301 from 544-COLUMBIA (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24712P0963 | GEORGIA BUREAU OF INVESTIGATION | 544-COLUMBIA | $15,000 | FY2012 |
| VA557C15083 | ORTHO-CLINICAL DIAGNOSTICS INC | 544-COLUMBIA | $462,000 | FY2011 |
| VA445C15083 | ORTHO-CLINICAL DIAGNOSTICS INC | 544-COLUMBIA | $0 | FY2011 |
| VA508C15254 | MYRIAD GENETIC LABORATORIES INC | 544-COLUMBIA | $30,000 | FY2011 |
| VA544C15026 | TOSOH BIOSCIENCE, INC. | 544-COLUMBIA | $86,040 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24712F0031_3600_V797P5478X_3600 · retrieved 2026-09-26.